Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Manjer

Showing results (121-130 of 309) with videos related to

Pageof 31
Sort By:
British Journal of Cancer|March 8, 2025
Statin use and risk of breast cancer among women with benign breast disease: a Danish nationwide cohort studyCharlotte Skriver, Deirdre Cronin-Fenton, Signe Borgquist, et al.
Cancer|October 21, 2010
Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50Hans Lilja, Angel M Cronin, Anders Dahlin, et al.
Redox Biology|May 31, 2022
Autoimmunity to selenoprotein P predicts breast cancer recurrenceKamil Demircan, Qian Sun, Ylva Bengtsson, et al.
International Journal of Cancer|November 25, 2010
A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNPSophia Harlid, Malin I L Ivarsson, Salma Butt, et al.
Scientific Reports|May 5, 2017
Associations between prediagnostic blood glucose levels, diabetes, and gliomaJudith Schwartzbaum, Michael Edlinger, Victoria Zigmont, et al.
International Journal of Epidemiology|October 1, 2019
BMI and weight changes and risk of obesity-related cancers: a pooled European cohort studyTone Bjørge, Christel Häggström, Sara Ghaderi, et al.
Journal of Translational Medicine|September 23, 2023
Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective studyKamil Demircan, Ylva Bengtsson, Thilo Samson Chillon, et al.
Journal of Translational Medicine|August 24, 2010
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancerAsa Ehlén, Donal J Brennan, Björn Nodin, et al.
Epidemiology (Cambridge, Mass.)|September 11, 2014
Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrationsChristel Häggström, Tanja Stocks, Gabriele Nagel, et al.
European Urology|November 22, 2011
Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened menRobert J Klein, Christer Hallden, Amit Gupta, et al.
Pageof 31

Showing results (121-130 of 309) with videos related to

Sort By:
Pageof 31
British Journal of Cancer|March 8, 2025
Statin use and risk of breast cancer among women with benign breast disease: a Danish nationwide cohort studyCharlotte Skriver, Deirdre Cronin-Fenton, Signe Borgquist, et al.
Cancer|October 21, 2010
Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50Hans Lilja, Angel M Cronin, Anders Dahlin, et al.
Redox Biology|May 31, 2022
Autoimmunity to selenoprotein P predicts breast cancer recurrenceKamil Demircan, Qian Sun, Ylva Bengtsson, et al.
International Journal of Cancer|November 25, 2010
A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNPSophia Harlid, Malin I L Ivarsson, Salma Butt, et al.
Scientific Reports|May 5, 2017
Associations between prediagnostic blood glucose levels, diabetes, and gliomaJudith Schwartzbaum, Michael Edlinger, Victoria Zigmont, et al.
International Journal of Epidemiology|October 1, 2019
BMI and weight changes and risk of obesity-related cancers: a pooled European cohort studyTone Bjørge, Christel Häggström, Sara Ghaderi, et al.
Journal of Translational Medicine|September 23, 2023
Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective studyKamil Demircan, Ylva Bengtsson, Thilo Samson Chillon, et al.
Journal of Translational Medicine|August 24, 2010
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancerAsa Ehlén, Donal J Brennan, Björn Nodin, et al.
Epidemiology (Cambridge, Mass.)|September 11, 2014
Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrationsChristel Häggström, Tanja Stocks, Gabriele Nagel, et al.
European Urology|November 22, 2011
Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened menRobert J Klein, Christer Hallden, Amit Gupta, et al.
Pageof 31